4//SEC Filing
Mulligan Seamus 4
Accession 0001765581-20-000075
CIK 0001232524other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:47 PM ET
Size
7.2 KB
Accession
0001765581-20-000075
Insider Transaction Report
Form 4
Mulligan Seamus
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2020-08-06+6,765→ 6,765 totalExercise: $127.07Exp: 2030-08-05→ Ordinary Shares (6,765 underlying) - Award
Ordinary Shares
2020-08-06+2,705→ 1,155,493 total
Footnotes (2)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 30, 2021.
- [F2]These options are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in full on July 30, 2021.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001536639
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:47 PM ET
- Size
- 7.2 KB